Background: The population of individuals affected by breast cancer is growing, and with advances in cancer treatment implemented into usual care, there is an urgent need to improve the recognition, monitoring and treatment of therapy-induced adverse effects. This study aims to explore the use of an in-app electronic questionnaire to assess and monitor chemotherapy-related symptoms in early breast cancer patients treated with perioperative chemotherapy.
Method: Between December 2019 and June 2021, 72 female study participants used the mobile app and completed an in-app questionnaire about the 14 most common chemotherapy-related symptoms.